Bringing the fundamentals into focus…
Back to Strata Critical Medical, Inc.
How Strata Critical Medical, Inc. stacks up
SRTA · against 409 other Healthcare companies of similar size
Valuation
78/ 100
Near the top of its peers.
Ranked #91 of 410 · scores higher than 77% of peers
Bars: peers in each 10-point band of the valuation score40 peers with a valuation score of 70–79, including SRTA · Click a bar to see the companies
Why valuation scores 78?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -12.3% vs peer median 0.0%
- lower earnings for the price paid: weaker than 75% of peers. Earnings yield: 10.2% vs peer median 1.5%
- less operating profit (EBITDA) for the company's total value: weaker than 61% of peers. EBITDA yield: 1.9% vs peer median 4.0%
Metric by metric
Position: dot = SRTA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | SRTA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 396 reported | -6.3% | 0.0% | 35% | 30% | |
| EBITDA yieldHigher is better · 415 reported | 1.9% | 3.0% | 47% | 50% | |
| Free cash flow yieldHigher is better · 195 reported | -12.6% | -8.4% | 39% | 20% | |
| Book yieldHigher is better · 407 reported | 71.1% | 50.1% | 69% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around SRTAScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score